| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8957263 | The Journal of Heart and Lung Transplantation | 2018 | 10 Pages |
Abstract
UA is an independent predictor of CAV after HT. Sirolimus is associated with decreased UA levels and may explain one of the mechanisms by which sirolimus attenuates CAV progression.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rabea MD, PhD, MHA, Megha MD, Alexandros MD, PhD, Valentina MD, Rosalyn MD, PharmD, Brooks S. MD, Naveen L. MD, Richard C. MD, Amir MD, Sudhir S. MD,